US · guidance
CMS Pub. 100-03, ch. 1, § 50.7
Cochleostomy With Neurovascular Transplant for Meniere’s
Disease
(Rev. 1, 10-03-03)
CIM 35-50
Not Covered
Meniere’s disease (or syndrome) is a common cause of paroxysmal vertigo. Meniere’s
syndrome is usually treated medically. When medical treatment fails, surgical treatment
may be required.
While there are two recognized surgical procedures used in treating Meniere’s disease
(decompression of the endolymphatic hydrops and labyrinthectomy), there is no scientific
evidence supporting the safety and effectiveness of cochleostomy with neurovascular
transplant in treatment of Meniere’s syndrome. Accordingly, Medicare does not cover
cochleostomy with neurovascular transplant for treatment of Meniere’s disease.
History
(Rev. 1, 10-03-03)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
e54c59df45f924476ef98e4251d5e84cec80a5ccbbffb3070fdf9854dd936fe1
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.